Sonio's AI technology for prenatal screening will enhance Samsung Medison's capabilities in providing efficient and accurate diagnostic solutions.
 |
| The acquisition of Sonio will enable Samsung Medison to offer more advanced and efficient diagnostic solutions to healthcare providers worldwide. Symbolic Image |
Seoul, South Korea – September 2, 2024:
Samsung Medison, a leading medical equipment manufacturer and a subsidiary of Samsung Electronics, has significantly enhanced its artificial intelligence (AI) capabilities through the acquisition of Sonio, a French startup specializing in AI-powered diagnostic solutions for obstetrics and gynecology ultrasound.
The acquisition of Sonio marks a strategic move for Samsung Medison as it seeks to expand its presence in the rapidly evolving healthcare technology market. By combining Sonio's advanced AI technology with Samsung's expertise in medical equipment, the company aims to develop innovative solutions that improve patient care and streamline medical workflows.
Sonio's flagship product, Sonio Detect, is a cutting-edge AI software designed to automate the analysis of ultrasound images for prenatal syndromes and abnormalities. This technology has garnered significant attention and has already received regulatory approval from the U.S. Food and Drug Administration.
The integration of Sonio's AI capabilities into Samsung Medison's product line is expected to yield several benefits. Firstly, it will enable more accurate and efficient diagnosis of prenatal conditions, leading to earlier detection and intervention. Secondly, it will reduce the workload of healthcare professionals, allowing them to focus on more complex cases and improve patient outcomes. Finally, it will contribute to closing the global healthcare gap by providing access to advanced diagnostic tools in regions with limited resources.
Samsung Medison's acquisition of Sonio is a testament to the company's commitment to innovation and its belief in the transformative power of AI in healthcare. By investing in cutting-edge technology and talent, Samsung Medison is positioning itself as a leader in the development of AI-driven medical solutions.